1. Hanmi Science Q2 2025 Earnings: What Happened?

Hanmi Science released its Q2 2025 earnings on July 25, 2025. While revenue slightly decreased compared to the previous quarter, operating profit surged by 27% to ₩34.6 billion, and net income increased by 18% to ₩28.8 billion.

2. What Drove the Profit Growth?

The substantial increase in operating and net profit despite a slight dip in revenue suggests successful cost optimization and improved profit margins. The concerns regarding rising operating expenses highlighted in the Q1 report appear to have been mitigated, or positive factors such as a decrease in cost of goods sold may have contributed to the improved profitability.

3. What Does This Mean for Investors?

The Q2 earnings release reinforces a positive outlook on Hanmi Science’s fundamentals. Continued growth in the healthcare sector is also a positive sign. However, the ongoing management dispute remains a source of uncertainty. External factors such as exchange rates, raw material prices, interest rates, and the potential for a global economic slowdown warrant careful monitoring.

4. Investment Strategy: What Should You Do?

While short-term upward momentum in the stock price is anticipated, a long-term investment perspective requires a comprehensive assessment of the management dispute resolution, the sustainability of operating profit improvement, and changes in the external environment. Further analysis of the detailed earnings report is crucial for refining investment strategies.